Mandate

Vinge advises EQT Infrastructure II fund on the acquisition of Hector Rail

September 16, 2014

Vinge advises EQT Infrastructure II fund in connection with the acquisition of a majority stake in Hector Rail AB, a leading Sweden-based independent rail freight company, from investment entities advised by Höegh Capital Partners, the founders Mats Nyblom and Ole Kjörrefjord, and other minority owners. Hector Rail was founded in 2004, supported by the Norwegian Høegh family. The Company, headquartered in Stockholm, Sweden, has around 190 employees operating in Sweden, Norway, Denmark and Germany.

Hector Rail offers environmentally friendly transportation services of heavy industry products, raw materials, intermodal freight and passengers to clients such as industrial companies, forwarders, and other rail companies under medium term contracts. The Company currently operates a fleet of around 50 locomotives and 10 shunters performing over 6 million train kilometres per year. Revenues amounted to approximately SEK 630 million in 2013.

Vinge’s team consisted of responsible partner Daniel Rosvall together with, amongst others, project manager Matthias Pannier and associate Maria Dahlin (all corporate).

Related

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026

Vinge advises NEWS, a portfolio company of Litorina, in connection with the sale of Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG

Vinge advises Northern Environmental and Water Solutions AB (“NEWS”), a portfolio company of Litorina, in connection with the sale of the operating subsidiaries Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG (Vienna Stock Exchange: WIE). The transaction is expected to be completed in Q2 2026.
March 24, 2026

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026